Letter: CYP2C19 polymorphisms and exacerbation of rabeprazole's effects on celecoxib-induced small bowel injury—authors' reply

Y. Nuki, M. Esaki

Research output: Contribution to journalLetter

Original languageEnglish
Number of pages1
JournalAlimentary Pharmacology and Therapeutics
Volume46
Issue number7
DOIs
Publication statusPublished - Oct 2017

Fingerprint

Celecoxib
Rabeprazole
Wounds and Injuries
Cytochrome P-450 CYP2C19

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Gastroenterology
  • Pharmacology (medical)

Cite this

@article{1bbf803042fd4517b4b978dcbc9eec0d,
title = "Letter: CYP2C19 polymorphisms and exacerbation of rabeprazole's effects on celecoxib-induced small bowel injury—authors' reply",
author = "Y. Nuki and M. Esaki",
year = "2017",
month = "10",
doi = "10.1111/apt.14264",
language = "English",
volume = "46",
journal = "Alimentary Pharmacology and Therapeutics",
issn = "0269-2813",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Letter

T2 - CYP2C19 polymorphisms and exacerbation of rabeprazole's effects on celecoxib-induced small bowel injury—authors' reply

AU - Nuki, Y.

AU - Esaki, M.

PY - 2017/10

Y1 - 2017/10

UR - http://www.scopus.com/inward/record.url?scp=85028979575&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028979575&partnerID=8YFLogxK

U2 - 10.1111/apt.14264

DO - 10.1111/apt.14264

M3 - Letter

C2 - 28880441

AN - SCOPUS:85028979575

VL - 46

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

SN - 0269-2813

IS - 7

ER -